HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Zunino Selected Research

IDN 5109 (BAY 59-8862)

12/2001A novel taxane active against an orthotopically growing human glioma xenograft.
6/2001A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes.
5/2000Oral efficacy and bioavailability of a novel taxane.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Zunino Research Topics

Disease

28Neoplasms (Cancer)
05/2013 - 05/2000
16Carcinoma (Carcinomatosis)
09/2007 - 05/2000
5Melanoma (Melanoma, Malignant)
12/2004 - 05/2000
3Osteosarcoma (Osteogenic Sarcoma)
05/2006 - 06/2001
3Breast Neoplasms (Breast Cancer)
08/2001 - 05/2000
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2014 - 10/2000
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2004 - 11/2001
2Ovarian Neoplasms (Ovarian Cancer)
08/2002 - 05/2000
2Neoplasm Metastasis (Metastasis)
12/2001 - 10/2001
1Sarcoma (Soft Tissue Sarcoma)
05/2013
1Ewing Sarcoma (Sarcoma, Ewing)
05/2013
1Genomic Instability
01/2005
1Papillary Thyroid Cancer
07/2003
1Glioblastoma (Glioblastoma Multiforme)
03/2003
1Glioma (Gliomas)
12/2001
1Brain Neoplasms (Brain Tumor)
12/2001
1Central Nervous System Neoplasms
12/2001
1Squamous Cell Carcinoma of Head and Neck
11/2001
1Neutropenia
11/2001
1Prostatic Neoplasms (Prostate Cancer)
09/2001
1Poisoning
04/2001
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2000
1Lung Neoplasms (Lung Cancer)
08/2000

Drug/Important Bio-Agent (IBA)

13Cisplatin (Platino)FDA LinkGeneric
03/2014 - 07/2000
9PlatinumIBA
03/2014 - 07/2000
9Pharmaceutical PreparationsIBA
03/2014 - 05/2000
9Paclitaxel (Taxol)FDA LinkGeneric
01/2005 - 05/2000
6DNA (Deoxyribonucleic Acid)IBA
01/2010 - 05/2000
6Topotecan (Hycamtin)FDA LinkGeneric
01/2005 - 10/2000
4Taxoids (Taxanes)IBA
06/2001 - 05/2000
33- (4'- hydroxy- 3'- adamantylbiphenyl- 4- yl)acrylic acidIBA
09/2007 - 03/2004
3BBR 3464 (BBR3464)IBA
04/2004 - 07/2000
3Proteins (Proteins, Gene)FDA Link
08/2002 - 08/2000
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2001 - 08/2001
3IDN 5109 (BAY 59-8862)IBA
12/2001 - 05/2000
3taxaneIBA
12/2001 - 06/2001
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2014 - 12/2004
2EnzymesIBA
05/2013 - 01/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2013 - 12/2001
2RetinoidsIBA
09/2007 - 03/2004
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2006 - 08/2000
2Glutathione (Reduced Glutathione)IBA
01/2006 - 08/2000
2IDN 5390IBA
04/2004 - 03/2003
2Complementary DNA (cDNA)IBA
04/2004 - 08/2002
2Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2003 - 08/2002
2Platinum Compounds (Compounds, Platinum)IBA
12/2002 - 12/2000
2ST 1481 (Gimatecan)IBA
10/2001 - 08/2001
2Doxorubicin (Adriamycin)FDA LinkGeneric
08/2001 - 01/2001
2Oxidants (Oxidizing Agents)IBA
07/2001 - 08/2000
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
07/2001 - 08/2000
2AnthracyclinesIBA
04/2001 - 01/2001
2Antineoplastic Agents (Antineoplastics)IBA
07/2000 - 05/2000
1Adenosine Triphosphate (ATP)IBA
03/2014
1Drug CombinationsIBA
03/2014
1LigandsIBA
03/2014
1SST 0001IBA
05/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2013
1AnticoagulantsIBA
05/2013
1Angiogenesis InhibitorsIBA
05/2013
1Heparin (Liquaemin)FDA LinkGeneric
05/2013
1heparanaseIBA
05/2013
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
05/2013
1Conditioned Culture MediaIBA
05/2013
1Tyrosine (L-Tyrosine)FDA Link
05/2013
1PoisonsIBA
01/2010
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
08/2009
1Type I Tumor Necrosis Factor ReceptorsIBA
12/2004
1Messenger RNA (mRNA)IBA
04/2004
1OxindolesIBA
07/2003
1Oncogene Proteins (Oncogene Protein)IBA
07/2003
1SurvivinIBA
08/2002
1Docetaxel (Taxotere)FDA Link
08/2002
1Gefitinib (Iressa)FDA Link
12/2001
1Antisense OligonucleotidesIBA
12/2001
1Castor Oil (Oil, Castor)IBA
11/2001
1Albumin-Bound PaclitaxelFDA Link
11/2001
1AlbuminsIBA
11/2001
1Hormones (Hormone)IBA
09/2001
1Mitoxantrone (Novantrone)FDA LinkGeneric
08/2001
1CamptothecinIBA
08/2001
1Multidrug Resistance-Associated ProteinsIBA
08/2001
1SugarsIBA
04/2001
1Anti-Bacterial Agents (Antibiotics)IBA
04/2001
1AminesIBA
02/2001
1IminesIBA
02/2001
1Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2001
1losoxantroneIBA
01/2001
1Protein Isoforms (Isoforms)IBA
01/2001
1BBR 3438IBA
01/2001
19 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
10/2000
17-cyanocamptothecinIBA
10/2000
1NF-kappa B (NF-kB)IBA
08/2000
1Transcription Factors (Transcription Factor)IBA
08/2000
1Sulfhydryl Compounds (Thiols)IBA
08/2000
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2000
1Cytotoxins (Cytolysins)IBA
07/2000

Therapy/Procedure

7Drug Therapy (Chemotherapy)
01/2006 - 06/2000
6Therapeutics
03/2014 - 12/2000
3Oral Administration
11/2004 - 10/2001
2Aftercare (After-Treatment)
12/2001 - 07/2000